Study Contributors
COVIDRIVE’s Study Contributors network consists of hospital and primary care study sites from 12 European countries: Austria, Belgium, Croatia, Finland, France, Germany, Iceland, Italy, Netherlands, Poland, Romania, Spain and the United Kingdom.

COVIDRIVE is open to include new study sites in its European network. For more information on how to join COVIDRIVE, please see section “Participate”
- BREATHE consortium (United Kingdom)
- Centro Interuniversitario per la Ricerca sull’Influenza e le altre Infezioni Trasmissibili (CIRI-IT, Italy)
- COVIREIVAC hospital network, France
- Finnish Institute for Health and Welfare (THL, Finland)
- Fisabio VAHNSI hospital network (Spain)
- German Centre for Infection Research (DZIF hospital network, Germany)
- GZIM and Forum Impfen Primary care networks (Germany)
- Hospital Universitario de Salamanca (Spain)
- Hospital Universitario Germans Trias i Pujol (Spain)
- Hospital Universitario La Paz (Spain)
- CHU UCL Hospital Mont-Godinne (Belgium)
- Hospital Universitario Vall d’Hebron hospital network (Spain)
- Iceland Directorate of Health (Iceland)
- Imperial College London Health Partners (United Kingdom)
- Medical University of Vienna and Klinik Favoriten Hospital (Austria)
- National Institute for Infectious Diseases, “Prof. Dr. Matei Bals” (Romania)
- National Institute of Public Health (Poland)
- North West E-health (United Kingdom)
- University Hospital Ghent (Belgium)
- CHU Hospital Saint Pierre Brussels (Belgium)
- Hospital Fran Mihaljevic Zagreb (Croatia)